BMS - Understanding and Influencing the Disease Trajectory of Rheumatoid Arthritis


Industry room 5
English
Satellite Symposia
03 June 2021 17:30 - 19:00

Learning objectives:

  • Explore new research on the genesis of loss of tolerance
  • Highlight the clinical potential of investigations into the at-risk state
  • Review the impact of utilizing targeted therapies earlier in disease for a biomarker-defined patient population

Presentations

Title Time Calendar .ics
Symposium Opening
03 June 2021 17:30 - 17:37 .ics
New Understanding of the Microbiome’s Influence on the Initiation of Autoimmunity
03 June 2021 17:37 - 17:54 .ics
The Potential of Intervention in the At-Risk RA State
03 June 2021 17:54 - 18:12 .ics
The Impact of Targeted Therapies Early in RA Development
03 June 2021 18:12 - 18:30 .ics
Q&A Session
03 June 2021 18:30 - 19:00 .ics